Copyright
©The Author(s) 2017.
World J Radiol. Jun 28, 2017; 9(6): 269-279
Published online Jun 28, 2017. doi: 10.4329/wjr.v9.i6.269
Published online Jun 28, 2017. doi: 10.4329/wjr.v9.i6.269
Table 1 Lung cancer staging, Tumor, Node, Metastasis staging 8th edition
T | Primary tumor | |
Tx | Cannot be assessed; Tumor in sputum/bronchial washings not in imaging/bronchoscopy | |
To | No evidence | |
Tis | Carcinoma in situ | |
T1 | ≤ 3 cm surrounded by lung/visceral pleura, not involving main bronchus | |
T1a(mi) | Minimally invasive adenocarcinoma | |
T1a | ≤ 1 cm | |
T1b | > 1 to ≤ 2 cm | |
T1c | > 2 to ≤ 3 cm | |
T2 | > 3 to ≤ 5 cm or Involves main bronchus without carina involvement or Visceral pleural invasion or atelectasis/post obstructive pneumonitis extending to hilum | |
T2a | > 3 to ≤ 4 cm | |
T2b | > 4 to ≤ 5 cm | |
T3 | > 5 to ≤ 7 cm or Separate tumor in same lobe or Direct invasion of chest wall (includes parietal pleura and superior sulcus)/parietal pericardium/phrenic nerve | |
T4 | > 7 cm or | |
Separate tumor in different lobe of ipsilateral lung or Invasion of heart/ great vessels/diaphragm/mediastinum/trachea/carina/esophagus/ recurrent laryngeal nerve/vertebral body | ||
N | Regional lymph node | |
Nx | Cannot be assessed | |
N0 | No involvement | |
N1 | Ipsilateral peribronchial and/or hilar nodes and intrapulmonary nodes | |
N2 | Ipsilateral mediastinal and/or subcarinal nodes | |
N3 | Contralateral mediastinal or hilar; ipsilateral/contralateral scalene/supraclavicular | |
M | Distant metastasis | |
M0 | No distant metastasis | |
M1 | Distant metastasis is present | |
M1a | Tumor (s) in contralateral lung; pleural/pericardial nodule/malignant effusion | |
M1b | Single extrathoracic metastasis | |
M1c | Multiple extrathoracic metastases, in one/more organs |
Table 2 Five-year survival per T stage of the 8th Tumor, Node, Metastasis staging system
5-yr survival | |
T1a | 92% |
T1b | 83%-86% |
T1c | 76%-81% |
T2a | 67%-74% |
T2b | 60%-65% |
T3 | 52%-57% |
T4 | 38%-47% |
Table 3 Five-year survival per N stage of the 8th Tumor, Node, Metastasis staging system
5-yr survival | |
N0 | 60% |
N1 | 37% |
N2 | 23% |
N3 | 9% |
Table 4 Median survival per M stage of the 8th Tumor, Node, Metastasis Staging system
Median survival (in months) | |
M1a | 11.4 |
M1b | 11.4 |
M1c | 6.3 |
Table 5 Stage Group in the 8th Tumor, Node, Metastasis staging system (9)
N0 | N1 | N2 | N3 | ||
T1/M0 | T1a | IA1 | IIB | IIIA | IIIB |
T1b | IA2 | IIB | IIIA | IIIB | |
T1c | IA3 | IIB | IIIA | IIIB | |
T2/M0 | T2a | IB | IIB | IIIA | IIIB |
T2b | IIA | IIB | IIIA | IIIB | |
T3/M0 | IIB | IIIA | IIIB | IIIC | |
T4/M0 | IIIA | IIIA | IIIB | IIIC | |
TX/M1 | M1a | IVA | IVA | IVA | IVA |
M1b | IVA | IVA | IVA | IVA | |
M1c | IVB | IVB | IVB | IVB |
Table 6 Five-year survival per stage group of the 8th Tumor, Node, Metastasis staging system (9)
5-yr survival | |
IA1 | 92% |
IA2 | 83% |
IA3 | 77% |
IB | 68% |
IIA | 60% |
IIB | 53% |
IIIA | 36% |
IIIB | 26% |
IIIC | 13% |
IVA | 10% |
IVB | 0% |
- Citation: Kay FU, Kandathil A, Batra K, Saboo SS, Abbara S, Rajiah P. Revisions to the Tumor, Node, Metastasis staging of lung cancer (8th edition): Rationale, radiologic findings and clinical implications. World J Radiol 2017; 9(6): 269-279
- URL: https://www.wjgnet.com/1949-8470/full/v9/i6/269.htm
- DOI: https://dx.doi.org/10.4329/wjr.v9.i6.269